| scholarly article | Q13442814 |
| P50 | author | Gretchen E. Diehl | Q73914593 |
| Matthew C Madison | Q88112062 | ||
| P2093 | author name string | David B Corry | |
| Farrah Kheradmand | |||
| Holger K Eltzschig | |||
| Xiaoyi Yuan | |||
| Cheng-Yen Chang | |||
| Ran You | |||
| Roger D Rossen | |||
| Cristian Coarfa | |||
| Li-Zhen Song | |||
| Ming Shan | |||
| Sarah Perusich | |||
| Lorraine Cornwell | |||
| Rick Wetsel | |||
| Bon Hee Gu | |||
| Rajapakshe Kimal | |||
| P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells | Q24670661 | ||
| Recent advances in the genetics of autoimmune disease | Q28238782 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| Activation and regulation of the inflammasomes | Q29615664 | ||
| Complement regulators and inhibitory proteins | Q33386110 | ||
| Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells | Q33457187 | ||
| C1q as an autocrine and paracrine regulator of cellular functions | Q39028351 | ||
| C1q: A fresh look upon an old molecule | Q39364237 | ||
| Cellular and molecular mechanisms of asthma and COPD. | Q39403255 | ||
| Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain | Q40306336 | ||
| Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study | Q43271779 | ||
| C1q arrests the cell cycle progression of fibroblasts in G(1) phase: role of the cAMP/PKA-I pathway | Q43546871 | ||
| T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response | Q45292627 | ||
| Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. | Q47874561 | ||
| Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. | Q50557641 | ||
| Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. | Q51030802 | ||
| Complement and the Regulation of T Cell Responses. | Q52574294 | ||
| CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. | Q53548568 | ||
| COPD in 2016: some answers, more questions. | Q55131706 | ||
| SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience | Q57089437 | ||
| Relative Contribution of C1q and Apoptotic Cell-Surface Calreticulin to Macrophage Phagocytosis | Q58212954 | ||
| Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease | Q58840453 | ||
| Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients | Q72477525 | ||
| In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells | Q80643410 | ||
| The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation | Q88535342 | ||
| The Challenge of Controlling the COPD Epidemic: Unmet Needs | Q88736631 | ||
| Extracellular adenosine-mediated modulation of regulatory T cells | Q33878542 | ||
| Antielastin autoimmunity in tobacco smoking-induced emphysema | Q34621456 | ||
| Complement regulation of T-cell alloimmunity. | Q35151737 | ||
| Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. | Q35227723 | ||
| Ongoing airway inflammation in patients with COPD who do not currently smoke | Q35533404 | ||
| Activation of C3a receptor is required in cigarette smoke-mediated emphysema | Q35680500 | ||
| Risk factors for rheumatoid arthritis | Q35821581 | ||
| Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. | Q35981460 | ||
| Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency | Q35992006 | ||
| The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. | Q36075960 | ||
| The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema | Q36134550 | ||
| Nanoparticulate carbon black in cigarette smoke induces DNA cleavage and Th17-mediated emphysema | Q36182550 | ||
| Relation between duration of smoking cessation and bronchial inflammation in COPD | Q36183908 | ||
| Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome | Q36190792 | ||
| C1q limits dendritic cell differentiation and activation by engaging LAIR-1 | Q36414882 | ||
| Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD) | Q36516546 | ||
| Fundamental role of C1q in autoimmunity and inflammation | Q36972852 | ||
| The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity | Q37119247 | ||
| Complement in human diseases: Lessons from complement deficiencies | Q37501005 | ||
| Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway | Q37521362 | ||
| COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype. | Q37572312 | ||
| Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema | Q37602184 | ||
| Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema | Q37641609 | ||
| Effects of tobacco smoke on immunity, inflammation and autoimmunity | Q37665006 | ||
| Prevention of autoimmune rheumatic disease: state of the art and future perspectives | Q37811620 | ||
| Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence | Q37990551 | ||
| COPD: definition and phenotypes | Q38186284 | ||
| The complement system in systemic lupus erythematosus: an update | Q38213193 | ||
| The paradoxical roles of C1q and C3 in autoimmunity | Q38498407 | ||
| The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide | Q38604593 | ||
| The critical role of epigenetics in systemic lupus erythematosus and autoimmunity | Q38891326 | ||
| Production of complement components by cells of the immune system. | Q38935414 | ||
| Complement in removal of the dead - balancing inflammation | Q38991044 | ||
| P921 | main subject | pulmonary emphysema | Q188605 |
| P577 | publication date | 2019-05-21 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Cigarette smoke-induced reduction of C1q promotes emphysema | |
| P478 | volume | 5 |
| Q90341768 | Individuals at risk of seropositive rheumatoid arthritis: the evolving story | cites work | P2860 |
Search more.